Möchten Sie über diese Zeitschrift informiert bleiben? Klicken Sie bitte auf die Buttons, um unsere Alerts zu abonnieren.
Möchten Sie über diese Zeitschrift informiert bleiben? Klicken Sie bitte auf die Buttons, um unsere Alerts zu abonnieren.
Aflatoxin and the aetiology of liver cancer and its implications for Guatemala
in World Mycotoxin JournalSearch for other papers by J.D. Groopman in
Current site
Google Scholar
Search for other papers by J.W. Smith in
Current site
Google Scholar
Search for other papers by A. Rivera-Andrade in
Current site
Google Scholar
Search for other papers by C.S. Alvarez in
Current site
Google Scholar
Search for other papers by M.F. Kroker-Lobos in
Current site
Google Scholar
Search for other papers by P.A. Egner in
Current site
Google Scholar
Search for other papers by E. Gharzouzi in
Current site
Google Scholar
Search for other papers by M. Dean in
Current site
Google Scholar
Search for other papers by K.A. McGlynn in
Current site
Google Scholar
Search for other papers by M. Ramírez-Zea in
Current site
Google Scholar
During the 60 years since the first scientific reports about a relation between aflatoxin exposure and adverse health consequences, both in animals and humans, there has been a remarkable number of basic, clinical and population science studies characterising the impact of this mycotoxin on diseases such as liver cancer. Many of these human investigations to date have focused on populations residing in Asia and Africa due to the high incidence of liver cancer and high exposures to aflatoxin. These studies formed the basis for the International Agency for Research on Cancer to classify the aflatoxins as Group 1 known human carcinogens. In addition, aflatoxin contamination levels have been used in international commodity trade to set the price of various staples such as maize and groundnuts. While there have been many case-control and prospective cohort studies of liver cancer risk over the years there have been remarkably few investigations focused on liver cancer in Latin America. Our interdisciplinary and multiple institutional collaborative has been developing a long-term strategy to characterise the role of aflatoxin and other mycotoxins as health risk factors in Guatemala and neighbouring countries. This paper summarises a number of the investigations to date and provides a roadmap of our strategies for the near term to discern the emergent aetiology of liver cancer in this region. With these data in hand public health-based prevention strategies could be strategically implemented and conducted to lower the impact of these mycotoxins on human health.
Kauf
Sofortzugang erwerben (PDF-Download und unbegrenzter Online-Zugang):
Institutszugang
Melden Sie sich mit Open Athens, Shibboleth oder Ihren institutionellen Anmeldedaten an.
Persönliche Anmeldung
Melden Sie sich mit Ihrem brill.com-Konto an
-
Alexandrov, L.B., Nik-Zainal, S., Wedge, D.C., Aparicio, S.A., Behjati, S., Biankin, A.V., Bignell, G.R., Bolli, N., Borg, A., Borresen-Dale, A.L., Boyault, S., Burkhardt, B., Butler, A.P., Caldas, C., Davies, H.R., Desmedt, C., Eils, R., Eyfjord, J.E., Foekens, J.A., Greaves, M., Hosoda, F., Hutter, B., Ilicic, T., Imbeaud, S., Imielinski, M., Jager, N., Jones, D.T., Jones, D., Knappskog, S., Kool, M., Lakhani, S.R., Lopez-Otin, C., Martin, S., Munshi, N.C., Nakamura, H., Northcott, P.A., Pajic, M., Papaemmanuil, E., Paradiso, A., Pearson, J.V., Puente, X.S., Raine, K., Ramakrishna, M., Richardson, A.L., Richter, J., Rosenstiel, P., Schlesner, M., Schumacher, T.N., Span, P.N., Teague, J.W., Totoki, Y., Tutt, A.N., Valdes-Mas, R., van Buuren, M.M., van ‘t Veer, L., Vincent-Salomon, A., Waddell, N., Yates, L.R., Australian Pancreatic Cancer Genome, I., Consortium, I.B.C., Consortium, I.M.-S., PedBrain, I., Zucman-Rossi, J., Futreal, P.A., McDermott, U., Lichter, P., Meyerson, M., Grimmond, S.M., Siebert, R., Campo, E., Shibata, T., Pfister, S.M., Campbell, P.J. and Stratton, M.R., 2013. Signatures of mutational processes in human cancer. Nature 500: 415-421.https://doi.org/10.1038/nature12477
-
Alvarez, C.S., Hernandez, E., Escobar, K., Villagran, C.I., Kroker-Lobos, M.F., Rivera-Andrade, A., Smith, J.W., Egner, P.A., Lazo, M., Freedman, N.D., Guallar, E., Dean, M., Graubard, B.I., Groopman, J.D., Ramirez-Zea, M. and McGlynn, K.A., 2020a. Aflatoxin B1 exposure and liver cirrhosis in Guatemala: a case-control study. BMJ Open Gastroenterology 7: 380.https://doi.org/10.1136/bmjgast-2020-000380
-
Alvarez, C.S., Ortiz, J., Bendfeldt-Avila, G., Xie, Y., Wang, M., Wu, D., Higson, H., Lee, E., Teshome, K., Barnoya, J., Kleiner, D.E., Groopman, J.D., Orozco, R., McGlynn, K.A., Gharzouzi, E. and Dean, M., 2020b. Analysis of TP53 aflatoxin signature mutation in hepatocellular carcinomas from Guatemala: a cross-sectional study (2016-2017). Health Science Reports 3: e155.https://doi.org/10.1002/hsr2.155
-
Anonymous, 2014. World Cancer Report 2014. International Agency for Research on Cancer, Lyon, France.
-
Anstee, Q.M., Reeves, H.L., Kotsiliti, E., Govaere, O. and Heikenwalder, M., 2019. From NASH to HCC: current concepts and future challenges. Nature Reviews Gastroenterology Hepatology 16: 411-428.https://doi.org/10.1038/s41575-019-0145-7
-
Arnold, M., Abnet, C.C., Neale, R.E., Vignat, J., Giovannucci, E.L., McGlynn, K.A. and Bray, F., 2020. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology 159: 335-349.https://doi.org/10.1053/j.gastro.2020.02.068
-
Arshad, T., Golabi, P., Henry, L. and Younossi, Z.M., 2020. Epidemiology of non-alcoholic fatty liver disease in North America. Current Pharmaceutical Design 26: 993-997.https://doi.org/10.2174/1381612826666200303114934
-
Asao, T., Buchi, G., Abdel-Kader, M., Chang, S., Wick, E. and Wogan, G.N., 1963. Aflatoxins B and G. Journal of the American Chemical Society 85: 1706-1707.
'Aflatoxins B and G ' () 85 Journal of the American Chemical Society : 1706 -1707.
-
Bosch, F.X. and Munoz, N., 1988. Review. Prospects for epidemiological studies on hepatocellular cancer as a model for assessing viral and chemical interactions. IARC Scientific Publications 89: 427-438.
'Review ' () 89 IARC Scientific Publications : 427 -438.
-
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A., 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 68: 394-424.https://doi.org/10.3322/caac.21492
-
Bressac, B., Kew, M., Wands, J. and Ozturk, M., 1991. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350: 429-431.https://doi.org/10.1038/350429a0
-
Chawanthayatham, S., Valentine, C.C., 3rd, Fedeles, B.I., Fox, E.J., Loeb, L.A., Levine, S.S., Slocum, S.L., Wogan, G.N., Croy, R.G. and Essigmann, J.M., 2017. Mutational spectra of aflatoxin B1 in vivo establish biomarkers of exposure for human hepatocellular carcinoma. Proceedings of the National Academy of Sciences of the USA 114: E3101-E3109.https://doi.org/10.1073/pnas.1700759114
-
Chen, J., Zhu, J., Wang, G., Groopman, J.D. and Kensler, T.W., 2019. Qidong: a crucible for studies on liver cancer etiology and prevention. Cancer Biology and Medicine 16: 24-37.https://doi.org/10.20892/j.issn.2095-3941.2018.0394
-
Chen, J.G., Egner, P.A., Ng, D., Jacobson, L.P., Munoz, A., Zhu, Y.-R., Qian, G., Wu, F., Yuan, J.-M., Groopman, J.D. and Kensler, T.W., 2013. Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China. Cancer Prevention Research 6: 1038-1045.https://doi.org/10.1158/1940-6207.capr-13-0168
-
Chen, J.G., Zhu, J., Parkin, D.M., Zhang, Y.H., Lu, J.H., Zhu, Y.R. and Chen, T.Y., 2006. Trends in the incidence of cancer in Qidong, China, 1978-2002. International Journal of Cancer 119: 1447-1454.
'Trends in the incidence of cancer in Qidong, China, 1978-2002 ' () 119 International Journal of Cancer : 1447 -1454.
-
Cupid, B.C., Lightfoot, T.J., Russell, D., Gant, S.J., Turner, P.C., Dingley, K.H., Curtis, K.D., Leveson, S.H., Turteltaub, K.W. and Garner, R.C., 2004. The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposure. Food and Chemical Toxicology 42: 559-569.https://doi.org/10.1016/j.fct.2003.10.015
-
De Campos, M. and Olszyna-Marzys, A.E., 1979. Aflatoxin contamination in grains and grain products during the dry season in Guatemala. Bulletin of Environmental Contamination and Toxicology 22: 350-356.
'Aflatoxin contamination in grains and grain products during the dry season in Guatemala ' () 22 Bulletin of Environmental Contamination and Toxicology : 350 -356.
-
De Campos, M., Santos, J. and Olszyna-Marzys, A.E., 1980. Aflatoxin contamination in grains from the Pacific coast in Guatemala and the effect of storage upon contamination. Bulletin of Environmental Contamination and Toxicology 24: 789-795.
'Aflatoxin contamination in grains from the Pacific coast in Guatemala and the effect of storage upon contamination ' () 24 Bulletin of Environmental Contamination and Toxicology : 789 -795.
-
De Ruyck, K., De Boevre, M., Huybrechts, I. and De Saeger, S., 2015. Dietary mycotoxins, co-exposure, and carcinogenesis in humans: short review. Mutation Research/Reviews in Mutation Research 766: 32-41.https://doi.org/10.1016/j.mrrev.2015.1007.1003.
-
El-Serag, H.B. and Kanwal, F., 2014. Epidemiology of hepatocellular carcinoma in the United States: where are we? Hepatology 60: 1767-1775.https://doi.org/10.1002/hep.27222.
-
Fedeles, B.I. and Essigmann, J.M., 2018. Impact of DNA lesion repair, replication and formation on the mutational spectra of environmental carcinogens: aflatoxin B1 as a case study. DNA Repair 71: 12-22.https://doi.org/10.1016/j.dnarep.2018.08.008
-
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D. and Bray, F., 2015. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer 136: E359-386.https://doi.org/10.1002/ijc.29210
-
Global Burden of Disease Liver Cancer, C., Akinyemiju, T., Abera, S., Ahmed, M., Alam, N., Alemayohu, M.A., Allen, C., Al-Raddadi, R., Alvis-Guzman, N., Amoako, Y., Artaman, A., Ayele, T.A., Barac, A., Bensenor, I., Berhane, A., Bhutta, Z., Castillo-Rivas, J., Chitheer, A., Choi, J.Y., Cowie, B., Dandona, L., Dandona, R., Dey, S., Dicker, D., Phuc, H., Ekwueme, D.U., Zaki, M.E.S., Fischer, F., Furst, T., Hancock, J., Hay, S.I., Hotez, P., Jee, S.H., Kasaeian, A., Khader, Y., Khang, Y.H., Kumar, G.A., Kutz, M., Larson, H., Lopez, A., Lunevicius, R., Malekzadeh, R., McAlinden, C., Meier, T., Mendoza, W., Mokdad, A., Moradi-Lakeh, M., Nagel, G., Nguyen, Q., Nguyen, G., Ogbo, F., Patton, G., Pereira, D.M., Pourmalek, F., Qorbani, M., Radfar, A., Roshandel, G., Salomon, J.A., Sanabria, J., Sartorius, B., Satpathy, M., Sawhney, M., Sepanlou, S., Shackelford, K., Shore, H., Sun, J., Mengistu, D.T., Topor-Madry, R., Tran, B., Ukwaja, K.N., Vlassov, V., Vollset, S.E., Vos, T., Wakayo, T., Weiderpass, E., Werdecker, A., Yonemoto, N., Younis, M., Yu, C., Zaidi, Z., Zhu, L., Murray, C.J.L., Naghavi, M. and Fitzmaurice, C., 2017. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015. JAMA Oncology 3: 1683-1691.https://doi.org/10.1001/jamaoncol.2017.3055
-
Groopman, J.D., Egner, P.A., Schulze, K.J., Wu, L.S., Merrill, R., Mehra, S., Shamim, A.A., Ali, H., Shaikh, S., Gernand, A., Khatry, S.K., LeClerq, S.C., West, K.P., Jr. and Christian, P., 2014. Aflatoxin exposure during the first 1000 days of life in rural South Asia assessed by aflatoxin B1-lysine albumin biomarkers. Food and Chemical Toxicology 74: 184-189.https://doi.org/10.1016/j.fct.2014.09.016
-
Groopman, J.D., Hall, A.J., Whittle, H., Hudson, G.J., Wogan, G.N., Montesano, R. and Wild, C.P., 1992. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa. Cancer Epidemiology, Biomarkers and Prevention 1: 221-227.
'Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa ' () 1 Cancer Epidemiology, Biomarkers and Prevention : 221 -227.
-
Groopman, J.D., Kensler, T.W. and Wu, F., 2013. Food safety: mycotoxins – occurrence and toxic effects. In: Caballero, B. (ed.) Encyclopedia of human nutrition (3rd ed.), Academic Press, Cambridge, MA, USA, pp. 337-341.https://doi.org/10.1016/b978-0-12-375083-9.00122-7
-
Hsu, I.C., Metcalf, R.A., Sun, T., Welsh, J.A., Wang, N.J. and Harris, C.C., 1991. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350: 427-428.https://doi.org/10.1038/350427a0
-
Kensler, T.W., Roebuck, B.D., Wogan, G.N. and Groopman, J.D., 2011. Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. Toxicological Science 120 Suppl. 1: S28-48.https://doi.org/10.1093/toxsci/kfq283
-
Khlangwiset, P., Shephard, G.S. and Wu, F., 2011. Aflatoxins and growth impairment: a review. Critical Reviews in Toxicology 41: 740-755.https://doi.org/10.3109/10408444.2011.575766
-
Kroker-Lobos, M.F., Alvarez, C.S., Rivera-Andrade, A., Smith, J.W., Egner, P., Torres, O., Lazo, M., Freedman, N.D., Guallar, E., Graubard, B.I., McGlynn, K.A., Ramirez-Zea, M. and Groopman, J.D., 2019. Association between aflatoxin-albumin adduct levels and tortilla consumption in Guatemalan adults. Toxicology Reports 6: 465-471.https://doi.org/10.1016/j.toxrep.2019.05.009
-
Kucab, J.E., Zou, X., Morganella, S., Joel, M., Nanda, A.S., Nagy, E., Gomez, C., Degasperi, A., Harris, R., Jackson, S.P., Arlt, V.M., Phillips, D.H. and Nik-Zainal, S., 2019. A compendium of mutational signatures of environmental agents. Cell 177: 821-836 e816.https://doi.org/10.1016/j.cell.2019.03.001
-
Liu, Y., Chang, C.C., Marsh, G.M. and Wu, F., 2012. Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis. European Journal of Cancer 48: 2125-2136.https://doi.org/10.1016/j.ejca.2012.02.009
-
Liu, Y. and Wu, F., 2010. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environmental Health Perspectives 118: 818-824.https://doi.org/10.1289/ehp.0901388
-
McCoy, L.F., Scholl, P.F., Schleicher, R.L., Groopman, J.D., Powers, C.D. and Pfeiffer, C.M., 2005. Analysis of aflatoxin B1-lysine adduct in serum using isotope-dilution liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry 19: 2203-2210.https://doi.org/10.1002/rcm.2045
-
McCoy, L.F., Scholl, P.F., Sutcliffe, A.E., Kieszak, S.M., Powers, C.D., Rogers, H.S., Gong, Y.Y., Groopman, J.D., Wild, C.P. and Schleicher, R.L., 2008. Human aflatoxin albumin adducts quantitatively compared by ELISA, HPLC with fluorescence detection, and HPLC with isotope dilution mass spectrometry. Cancer Epidemiology, Biomarkers and Prevention 17: 1653-1657.https://doi.org/10.1158/1055-9965.EPI-07-2780
-
McGlynn, K.A. and London, W.T., 2011. The global epidemiology of hepatocellular carcinoma: present and future. Clinical Liver Disease 15: 223-243.https://doi.org/10.1016/j.cld.2011.03.006
-
McGlynn, K.A., Petrick, J.L. and El-Serag, H.B., 2021. Epidemiology of hepatocellular carcinoma. Hepatology 73: 4-13.https://doi.org/10.1002/hep.31288
-
McGlynn, K.A., Petrick, J.L. and London, W.T., 2015. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clinical Liver Disease 19: 223-238.https://doi.org/210.1016/j.cld.2015.1001.1001
-
Ozturk, M., 1991. p53 mutation in hepatocellular carcinoma after aflatoxin exposure. The Lancet 338: 1356-1359.
'p53 mutation in hepatocellular carcinoma after aflatoxin exposure ' () 338 The Lancet : 1356 -1359.
-
Parkin, D.M., Bray, F., Ferlay, J. and Pisani, P., 2005. Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians 55: 74-108.
'Global cancer statistics, 2002 ' () 55 CA: A Cancer Journal for Clinicians : 74 -108.
-
Petrick, J.L., Kelly, S.P., Altekruse, S.F., McGlynn, K.A. and Rosenberg, P.S., 2016. Future of hepatocellular carcinoma incidence in the United States forecast through 2030. Journal of Clinical Oncology 34: 1787-1794.https://doi.org/10.1200/JCO.2015.64.7412
-
Pineros, M., Frech, S., Frazier, L., Laversanne, M., Barnoya, J., Garrido, C., Gharzouzi, E., Chacon, A., Fuentes Alabi, S., Ruiz de Campos, L., Figueroa, J., Dominguez, R., Rojas, O., Pereira, R., Rivera, C. and Morgan, D.R., 2018. Advancing reliable data for cancer control in the central America four region. Journal of Global Oncology 4: 1-11.https://doi.org/10.1200/JGO.2016.008227
-
Qian, G.S., Ross, R.K., Yu, M.C., Yuan, J.M., Gao, Y.T., Henderson, B.E., Wogan, G.N. and Groopman, J.D., 1994. A follow-up-study of urinary markers of aflatoxin exposure and liver-cancer risk in Shanghai, Peoples-Republic-of-China. Cancer Epidemiology Biomarkers and Prevention 3: 3-10.
'A follow-up-study of urinary markers of aflatoxin exposure and liver-cancer risk in Shanghai, Peoples-Republic-of-China ' () 3 Cancer Epidemiology Biomarkers and Prevention : 3 -10.
-
Rivera-Andrade, A., Kroker-Lobos, M.F., Lazo, M., Freedman, N.D., Smith, J.W., Torres, O., McGlynn, K.A., Groopman, J.D., Guallar, E. and Ramirez-Zea, M., 2019. High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: a population-based study. Nutrition, Metabolism and Cardiovascular Diseases 29: 191-200.https://doi.org/10.1016/j.numecd.2018.10.008
-
Ross, R.K., Yuan, J.M., Yu, M.C., Wogan, G.N., Qian, G.S., Tu, J.T., Groopman, J.D., Gao, Y.T. and Henderson, B.E., 1992. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. The Lancet 339: 943-946.
'Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma ' () 339 The Lancet : 943 -946.
-
Sabbioni, G., Ambs, S., Wogan, G.N. and Groopman, J.D., 1990. The aflatoxin-lysine adduct quantified by high-performance liquid chromatography from human serum albumin samples. Carcinogenesis 11: 2063-2066.
'The aflatoxin-lysine adduct quantified by high-performance liquid chromatography from human serum albumin samples ' () 11 Carcinogenesis : 2063 -2066.
-
Sabbioni, G., Skipper, P.L., Buchi, G. and Tannenbaum, S.R., 1987. Isolation and characterization of the major serum albumin adduct formed by aflatoxin B1in vivo in rats. Carcinogenesis 8: 819-824.
'Isolation and characterization of the major serum albumin adduct formed by aflatoxin B1in vivo in rats ' () 8 Carcinogenesis : 819 -824.
-
Smela, M.E., Currier, S.S., Bailey, E.A. and Essigmann, J.M., 2001. The chemistry and biology of aflatoxin B1: from mutational spectrometry to carcinogenesis. Carcinogenesis 22: 535-545.
'The chemistry and biology of aflatoxin B1: from mutational spectrometry to carcinogenesis ' () 22 Carcinogenesis : 535 -545.
-
Smith, J.W., Kroker-Lobos, M.F., Lazo, M., Rivera-Andrade, A., Egner, P.A., Wedemeyer, H., Torres, O., Freedman, N.D., McGlynn, K.A., Guallar, E., Groopman, J.D. and Ramirez-Zea, M., 2017. Aflatoxin and viral hepatitis exposures in Guatemala: molecular biomarkers reveal a unique profile of risk factors in a region of high liver cancer incidence. PLoS One 12: e0189255.https://doi.org/10.1371/journal.pone.0189255
-
Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J. and Jemal, A., 2015. Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians 65: 87-108.https://doi.org/110.3322/caac.21262
-
Torres, O., Matute, J., Gelineau-van Waes, J., Maddox, J., Gregory, S.G., Ashley-Koch, A.E., Showker, J.L., Voss, K.A. and Riley, R.T., 2015. Human health implications from co-exposure to aflatoxins and fumonisins in maize-based foods in Latin America: Guatemala as a case study. World Mycotoxin Journal 8: 143-159.
'Human health implications from co-exposure to aflatoxins and fumonisins in maize-based foods in Latin America: Guatemala as a case study ' () 8 World Mycotoxin Journal : 143 -159.
-
Torres, O., Matute, J., Gelineau-van Waes, J., Maddox, J.R., Gregory, S.G., Ashley-Koch, A.E., Showker, J.L., Zitomer, N.C., Voss, K.A. and Riley, R.T., 2014. Urinary fumonisin B1 and estimated fumonisin intake in women from high- and low-exposure communities in Guatemala. Molecular Nutrition and Food Research 58: 973-983.https://doi.org/10.1002/mnfr.201300481
-
Turner, P.C., Sylla, A., Gong, Y.Y., Diallo, M.S., Sutcliffe, A.E., Hall, A.J. and Wild, C.P., 2005. Reduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in west Africa: a community-based intervention study. The Lancet 365: 1950-1956.https://doi.org/10.1016/S0140-6736(05)66661-5
-
Vatanasapt, V., Martin, N., Sriplung, H., Chindavijak, K., Sontipong, S., Sriamporn, S., Parkin, D.M. and Ferlay, J., 1995. Cancer incidence in Thailand, 1988-1991. Cancer Epidemiology, Biomarkers and Prevention 4: 475-483.
'Cancer incidence in Thailand, 1988-1991 ' () 4 Cancer Epidemiology, Biomarkers and Prevention : 475 -483.
-
Wang, L.Y., Hatch, M., Chen, C.J., Levin, B., You, S.L., Lu, S.N., Wu, M.H., Wu, W.P., Wang, L.W., Wang, Q., Huang, G.T., Yang, P.M., Lee, H.S. and Santella, R.M., 1996. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. International Journal of Cancer 67: 620-625.https://doi.org/10.1002/(SICI)1097-0215(19960904)67:5<620::AID-IJC5>3.0.CO;2-W
-
Wild, C.P. and Gong, Y.Y., 2010. Mycotoxins and human disease: a largely ignored global health issue. Carcinogenesis 31: 71-82.https://doi.org/10.1093/carcin/bgp264
-
Wild, C.P., Garner, R.C., Montesano, R. and Tursi, F., 1986. Aflatoxin B1 binding to plasma albumin and liver DNA upon chronic administration to rats. Carcinogenesis 7: 853-858.
'Aflatoxin B1 binding to plasma albumin and liver DNA upon chronic administration to rats ' () 7 Carcinogenesis : 853 -858.
-
Wild, C.P., Gong, Y.Y. and Turner, P.C., 2010. Mycotoxins and human disease: a largely ignored global health issue. Carcinogenesis 31: 71-82.
'Mycotoxins and human disease: a largely ignored global health issue ' () 31 Carcinogenesis : 71 -82.
-
Wild, C.P., Hudson, G.J., Sabbioni, G., Chapot, B., Hall, A.J., Wogan, G.N., Whittle, H., Montesano, R. and Groopman, J.D., 1992. Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa. Cancer Epidemiology, Biomarkers and Prevention 1: 229-234.
'Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa ' () 1 Cancer Epidemiology, Biomarkers and Prevention : 229 -234.
-
Wild, C.P., Jiang, Y.Z., Allen, S.J., Jansen, L.A., Hall, A.J. and Montesano, R., 1990. Aflatoxin-albumin adducts in human sera from different regions of the world. Carcinogenesis 11: 2271-2274.
'Aflatoxin-albumin adducts in human sera from different regions of the world ' () 11 Carcinogenesis : 2271 -2274.
-
Wild, C.P., Miller, J.D. and Groopman, J.D., 2015. Mycotoxin control in low- and middle-income countries. IARC Working Group Report Volume 9. IARC, Lyon, France
'Mycotoxin control in low- and middle-income countries', ().
-
Wild, C.P., Weiderpass, E. and Stewart, B.W., 2020. World Cancer Report. IARC, Lyon, France.
'World Cancer Report', ().
-
Wogan, G.N., Kensler, T.W. and Groopman, J.D., 2012. Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review. Food Additives and Contaminants Part A 29: 249-257.https://doi.org/10.1080/19440049.2011.563370
-
Wogan, G.N. and Newberne, P.M., 1967. Dose-response characteristics of aflatoxin B1 carcinogenesis in the rat. Cancer Res 27: 2370-2376.
'Dose-response characteristics of aflatoxin B1 carcinogenesis in the rat ' () 27 Cancer Res : 2370 -2376.
-
Wu, F., Groopman, J.D. and Pestka, J.J., 2014. Public health impacts of foodborne mycotoxins. Annual Review of Food Science and Technology 5: 351-372.https://doi.org/10.1146/annurev-food-030713-092431
-
Younossi, Z., Anstee, Q.M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J. and Bugianesi, E., 2018. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nature Reviews Gastroenterololy Hepatology 15: 11-20.https://doi.org/10.1038/nrgastro.2017.109
-
Zhang, W., He, H., Zang, M., Wu, Q., Zhao, H., Lu, L.L., Ma, P., Zheng, H., Wang, N., Zhang, Y., He, S., Chen, X., Wu, Z., Wang, X., Cai, J., Liu, Z., Sun, Z., Zeng, Y.X., Qu, C. and Jiao, Y., 2017. Genetic features of aflatoxin-associated hepatocellular carcinomas. Gastroenterology 153: 249-262.https://doi.org/10.1053/j.gastro.2017.03.024
| Insgesamt | Letzte 365 Tage | In den letzten 30 Tagen | |
|---|---|---|---|
| Aufrufe von Kurzbeschreibungen | 1223 | 289 | 22 |
| Gesamttextansichten | 84 | 0 | 0 |
| PDF-Downloads | 72 | 0 | 0 |
Aflatoxin and the aetiology of liver cancer and its implications for Guatemala
in World Mycotoxin JournalSearch for other papers by J.D. Groopman in
Current site
Google Scholar
PubMed
Search for other papers by J.W. Smith in
Current site
Google Scholar
PubMed
Search for other papers by A. Rivera-Andrade in
Current site
Google Scholar
PubMed
Search for other papers by C.S. Alvarez in
Current site
Google Scholar
PubMed
Search for other papers by M.F. Kroker-Lobos in
Current site
Google Scholar
PubMed
Search for other papers by P.A. Egner in
Current site
Google Scholar
PubMed
Search for other papers by E. Gharzouzi in
Current site
Google Scholar
PubMed
Search for other papers by M. Dean in
Current site
Google Scholar
PubMed
Search for other papers by K.A. McGlynn in
Current site
Google Scholar
PubMed
Search for other papers by M. Ramírez-Zea in
Current site
Google Scholar
PubMed
During the 60 years since the first scientific reports about a relation between aflatoxin exposure and adverse health consequences, both in animals and humans, there has been a remarkable number of basic, clinical and population science studies characterising the impact of this mycotoxin on diseases such as liver cancer. Many of these human investigations to date have focused on populations residing in Asia and Africa due to the high incidence of liver cancer and high exposures to aflatoxin. These studies formed the basis for the International Agency for Research on Cancer to classify the aflatoxins as Group 1 known human carcinogens. In addition, aflatoxin contamination levels have been used in international commodity trade to set the price of various staples such as maize and groundnuts. While there have been many case-control and prospective cohort studies of liver cancer risk over the years there have been remarkably few investigations focused on liver cancer in Latin America. Our interdisciplinary and multiple institutional collaborative has been developing a long-term strategy to characterise the role of aflatoxin and other mycotoxins as health risk factors in Guatemala and neighbouring countries. This paper summarises a number of the investigations to date and provides a roadmap of our strategies for the near term to discern the emergent aetiology of liver cancer in this region. With these data in hand public health-based prevention strategies could be strategically implemented and conducted to lower the impact of these mycotoxins on human health.
| Insgesamt | Letzte 365 Tage | In den letzten 30 Tagen | |
|---|---|---|---|
| Aufrufe von Kurzbeschreibungen | 1223 | 289 | 22 |
| Gesamttextansichten | 84 | 0 | 0 |
| PDF-Downloads | 72 | 0 | 0 |
